|
|
| Biotechnologies Et Génétique > Etude de marché sectorielle |
| Affymetrix, Inc. and Microarrays |
|
|
|
|
€ 240,00 |
Editeur
: |
TriMark |
Langue
: |
Anglais |
Date de publication : |
Décembre 2007 |
Taille du document : |
16 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Target and Lead Validation
160 pages | Décembre 2000 |
The advent of brute force approaches to lead generation has highlighted a key bottleneck in drug development.
The issue is not how many new compounds can one make per day, but rather how many c |
1 400,00 €
|
| |
| |
Carbohydrate Therapeutics
180 pages | Décembre 2000 |
Carbohydrates are the only class of biological molecule (there are four main classes: nucleic acids, proteins, lipids, and carbohydrates - commonly known as sugars), that can be found in direct associ |
1 400,00 €
|
| |
| |
Arthritis Drug Discovery IRCD
pages | Juin 2001 |
Arthritis (from the Greek for joint) is a chronic multi-factorial disease of the joints, induced when the immune system attacks and begins degrading the joints.
The disease knows no racial boun |
1 026,17 €
|
| |
| |
Bioinformatics
150 pages | Décembre 2000 |
Automation has assaulted several levels of biological research generating vast amounts of data.
Great leaps in DNA sequencing technology and automation led to a dramatic increase in sequence th |
1 400,00 €
|
| |
| |
Integrating Genomics: The Next Generation
124 pages | Février 1999 |
Genomics research : Understand the key technologies including target identification (genome mapping, random sequencing and two-hybrid assay), target validation/assay development and current appli |
795,00 €
|
| |
| |
NanoBioTechnology: Trends and Technological Developments
18 pages | Février 2003 |
Nanobiotechnology is being projected as a great scientific and technological opportunity for the Bio world.
It is widely recognized as one of the most beneficial areas of nanotechnology to industry |
450,00 €
|
| |
| |
Chinese Markets for Biotechnology
153 pages | Janvier 2002 |
China's demand for biotechnology has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic t |
2 835,00 €
|
| |
| |
03-010: The Market for Toxicogenomics Products & Services
193 pages | Avril 2003 |
This report provides a look at service providers, informatics products, microarrays and databases from the end-user's perspective |
640,00 €
|
| |
| |
Bioinformatics IR
pages | Juillet 2001 |
There is little doubt that biology is going large-scale.
Great leaps in high throughput technologies fueled by the genome sequencing projects, gene expression analysis and proteomics, to name but a |
1 600,00 €
|
| |
| |
Antisense Therapy: Technical Aspects and Commercial Opportunities
334 pages | Mars 2000 |
Antisense therapy interferes with the expression of disease-causing proteins, thus offering a direct and selective intervention in the disease process.
Besides the well known oligonucleotides ( |
955,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Affymetrix, Inc. and Microarrays |
|
|
This TriMark Publications ``Company Business Analysis and Segment Overview`` (CBASO) is designed to provide a concise executive summary of a leading company in a particular industry and that company's applicable sector focus. This CBASO provides a strategic analysis of the Affymetrix and its GeneChip microarray device: including its strengths, opportunities, weaknesses and threats. In the process, this CBASO takes a look at the functionality of the GeneChip, detailing its features, pricing and operator deployments. It also looks at Affymetrix's partners and third party solutions providers.
|
|
|
PPLSEN
|
|
|
|
|
